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The free radical nitric oxide (NO) is an important signaling molecule in the gastrointestinal tract. Besides eukaryotic cells, gut
microorganisms are also capable of producing NO. However, the exact mechanism of NO production by the gut microorganisms
is unknown. Microbial NO production was examined under in vitro conditions simulating the gastrointestinal ecosystem using
L-arginine or nitrate as substrates. L-arginine did not influence the microbial NO production. However, NO concentrations in
the order of 90 ng NO-N per L feed medium were produced by the fecal microbiota from nitrate. 15N tracer experiments showed
that nitrate was mainly reduced to ammonium by the dissimilatory nitrate reduction to ammonium (DNRA) pathway. To our
knowledge, this is the first study showing that gastrointestinal microbiota can generate substantial amounts of NO by DNRA and
not by the generally accepted denitrification or L-arginine pathway. Further work is needed to elucidate the exact role between NO
produced by the gastrointestinal microbiota and host cells.
Copyright © 2009 Joan Vermeiren et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Introduction
Nitric oxide (NO), a free radical with moderate reactivity, has
emerged as an important signaling molecule in a multitude
of physiological systems in the human body [1]. In the
gastrointestinal tract, NO is involved in the regulation of
regional blood flow, smooth muscle relaxation, secretory
and immunological regulation [2]. During inflammation the
production of NO is induced. Rectal NO concentrations in
healthy volunteers (range 3–25 ppbv) are significantly lower
than the concentrations in patients with active inflammatory
bowel disease (IBD) (range 71–8978 ppbv) [3]. NO can
be synthesized in eukaryotic cells through oxidation of L-
arginine by NO synthase (NOS) [4, 5]. Depending on
the isoform of NOS catalyzing the reaction, nanomo-
lar (endothelial NOS and neuronal NOS) or micromolar
(inducible NOS) NO concentrations are produced serving as
a messenger or as an antibacterial agent. Besides eukaryotic
NO production, it is well known that NO can be produced
also by microorganisms.
A first way of microbial NO synthesis can be achieved
from L-arginine by bacterial NOS (bNOS) with features
resembling the eukaryotic NOS (eukNOS). bNOS activity
has been described in a group of Gram-positive bacteria
[6–14] and genome sequencing has revealed genes coding
for similar proteins that are however shorter than the
eukNOS [15]. bNOS from Bacillus subtilis, Bacillus anthracis,
Deinococcus radiodurans, and Streptomyces spp. display NO-
forming activity in vivo dependent on arginine [14–17].
Besides L-arginine, nitrate and nitrite can also serve as an
N-source for NO. Per day, between 0 and 10 mg NO3
−-N
can reach the large intestine in healthy persons [18]. Feces
were shown to contain around 0.15 mg NO3
−-N/L [3]. In
vitro studies showed a correlation between the concentration
of the added nitrate or nitrite and the concentration of
NO produced by the fecal microbiota [19]. The metabolic
process best known for the microbial production of NO, and
extensively described in soils, sediments and water treatment
plants, is denitrification [20]. This dissimilatory process
uses oxidized nitrogen species as final electron acceptors
when oxygen levels are limiting. During the denitrification
process nitrate or nitrite is reduced to N2 gas with NO and
N2O as intermediates [21]. At steady-state conditions, the
NO concentrations range between 14 and 900 ng NO-N/L
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aqueous phase depending on species and conditions [22].
Another NO producing mechanism is by the reduction of
nitrite. For lactobacilli and bifidobacteria it is not clear
whether NO production from nitrite occurred biologically
or chemically. Hence, acidic nonenzymatic reduction of
nitrite was suggested as the predominant pathway for
NO production in vitro by lactic acid producing bacteria
(lactobacilli and bifidobacteria) as the produced organic
acids decrease the pH of the agar plates to 4 [19]. Whereas
NO production by lactic acid bacteria was considered to be
chemical, NO production from nitrite by Escherichia coli and
Salmonella typhimurium was shown to be biological. The
enzymes responsible for the NO formation from nitrite in
E. coli and S. typhimurium are periplasmic and cytoplasmic
nitrite reductase and nitrate reductase, respectively [23, 24].
To date, the relevance and mechanism of bacterial NO
production under gastrointestinal conditions remain elusive.
With NO being produced by inducible NOS in epithelial
cells as a response to cytokines and bacterial products [25],
it is of interest to know whether bacterial NO production
can occur under gastrointestinal conditions. The objective of
our study was to unravel the mechanisms by which human
fecal microbiota are able to produce NO in vitro. Three
possible pathways were considered (i) L-arginine as substrate
for NO synthase, (ii) denitrification to nitrogen gas and
(iii) dissimilatory nitrate reduction to ammonium (DNRA).
The latter was considered as fermentative nitrate reduction
is expected under gastrointestinal conditions however no
relation with NO production has been considered [26, 27].
2. Materials and Methods
2.1. Growth Media. NO production was examined in a min-
eral and a complex medium. The mineral medium G4M3 is
a medium optimized for denitrification [28]. Feed medium
is a complex medium simulating the nutritional conditions
in the colon. It is composed of arabinogalacton (1 g/L),
pectin (2 g/L), xylan (1 g/L), starch (3 g/L), glucose (0.4 g/L),
yeast extract (3 g/L), peptone (1 g/L), mucin (4 g/L), and
L-cysteine (0.5 g/L) [29]. L-cysteine was added to scavenge
dissolved oxygen and to lower the initial redox potential.
Analyses of the feed medium with ion chromatography
indicated that very low concentrations of nitrate, that is,
110± 50μg NO3−-N/L, were present.
2.2. Fecal Suspensions. Fecal samples were obtained from 6
healthy women with a mean age of 55.5 ranging between
53 and 59. Fecal suspensions were prepared and stored at
−80◦C until use [30]. The main group of organisms in fecal
samples belongs to the anaerobic Gram-positive bacteria.
Anaerobic populations belonging to the genera Bacteroidetes
and Firmicutes dominate [31, 32].
Incubations were performed with fecal suspension of
diﬀerent healthy persons which all showed similar results. In
the figures, the results of incubations of one representative
person are shown.
2.3. Batch Experiments. Anaerobic incubations were per-
formed in penicillin flasks with a total volume of 120 mL.
The bottles were filled with 50 mL of one of the growth
media and the pH was set at 7.0 using a 1 M NaOH solution.
The headspace (70 mL) was flushed for 45 minutes with
N2-gas to create anaerobic conditions. Diﬀerent parameters
(growth media, concentrations of nitrate and L-arginine,
pH, dilution of the fecal suspension and supernatant) were
varied to examine their eﬀect on the production of NO, as
described in Figure 1. For mineral media the concentration
of nitrate added was the only parameter tested. Nitrate as a
possible N-source for NO was added in concentrations of 5
and 50 mg NO3
−-N/L using a 14 g NaNO3−-N/L solution.
To study L-arginine as N-source, a stock solution of 3.5 g
(L-arginine-HCl)-N/L was added to final concentrations
of 5 and 50 mg L-arginine-N/L. When incubations were
performed in buﬀered feed medium, a 1 M phosphate buﬀer
(88 g K2HPO4/L and 68 g KH2PO4/L) was added to a final
concentration of 150 mM. The pH was measured before and
after incubation. Dilutions of the fecal suspension (1/2, 1/10,
1/20, 1/200, and 1/2000) were made in saline (8.5 g NaCl/L).
Both for the undiluted and diluted fecal suspensions, 1 mL
was inoculated in the growth medium. To study the eﬀect of
the supernatant of the fecal suspension on NO production,
the fecal suspension was centrifuged at 10 000 g for 15
minutes. The supernatant was collected and 1 mL was added
to the growth medium. The penicillin flasks were incubated
at 37◦C for 24 hours while shaking at 130 rpm.
To assess the production of NO during DNRA,
Escherichia coli K12 (LMG 18221) (BCCM culture collection,
Ghent University, Gent, Belgium) was grown anaerobically
for 24 hours at 37◦C in buﬀered feed medium without
additional nitrate.
2.4. 15N Batch Experiments. To determine the reduction of
nitrate to N2 or ammonium by, respectively, denitrification
or DNRA, an experiment was set up as described in the
section above but using a 14 g K15NO3
−-N/L (10 atom %)
solution to final concentrations of 5 and 50 mg 15NO3
−-N/L
(10 atom %). Atom % =15N/(14N +15N). The headspace was
flushed with Argon gas to avoid interference during 15N2
analyses. Fecal suspensions were added undiluted.
2.5. Simulator of the Human Intestinal Microbial Ecosystem
(SHIME). The reactor setup was adapted from the SHIME,
representing the diﬀerent parts of the adult human gut and
consisting of a succession of 5 compartments [29]. The first
2 compartments are a fill-and-draw setup and represent
the stomach and small intestine. Peristaltic pumps add a
defined amount of feed medium (140 mL, 3 times/day) and
pancreatic and bile liquid (60 mL, 3 times/day), respectively,
to the stomach and duodenum compartments and empty the
respective compartments after specified intervals. The last 3
compartments are continuously stirred reactors with con-
stant volume and pH control, specific for each compartment.
Upon inoculation with fecal microbiota, these reactors simu-
late the ascending, transverse, and descending colon. Inocu-
lum preparation, retention time, pH, temperature settings,
and reactor feed composition were described previously [33].
Closing oﬀ the gas phase of the diﬀerent colon compartments
(ascending, transverse, and descending) upon N2 flushing
Journal of Biomedicine and Biotechnology 3
Feed medium
No buﬀer Buﬀer
0.11 mg NO3−-N/L +5 mg NO3−-N/L +50 mg NO3−-N/L 0.11 mg NO3−-N/L +5 mg NO3−-N/L +50 mg NO3−-N/L
Diluted fecal slurry
Supernatant
Figure 1: Overview of the experimental setup for the diﬀerent parameters that were studied using feed medium simulating the conditions
in the human colon.
allowed to study the NO production in the respective colon
regions separately. Gas samples were collected and analyzed
for NO. Samples of the diﬀerent SHIME vessels of the 3
colon parts were collected. All the incubations were done
anaerobically in penicillin flasks of 120 mL, as described
previously. The suspensions were incubated as such or with
20 mL fresh feed medium. To test the eﬀect of the biomass,
the biomass of the suspensions was washed 3 times with
saline and resuspended in feed medium. The supernatant
was prepared by centrifuging the suspension at 10 000 g
for 15 minutes. The supernatant was filtersterilized using
0.22 μm membrane filters (Millipore, NYSE:MIL, USA) or
autoclaved.
2.6. Analytical Methods. Both NO3
− and NO2− concentra-
tions were measured before and after incubation of fecal
suspension in growth media supplemented with NO3
−.
A Metrohm 761 Compact Ion Chromatograph (Metrohm
AG, Herisau, Switzerland) equipped with a conductivity
detector and a Metrosep A supp 5 column was used.
The operational parameters were as follows: eluent 1.06 g
Na2CO3/L; flow 0.7 mL/min; sample loop 20 μL. The samples
were centrifuged at 4000 g for 3 minutes, filtered using
0.45 μm membrane filters, and diluted in milli-Q water
before analysis (Millipore, NYSE:MIL, USA).
During 15N experiments, NH4
+ concentrations were
determined colorimetrically by the salicylate-nitroprusside
method [34]. The amount of NO3
− and NO2− was measured
by first reducing NO3
− to NO2− by a copper-cadmium
redactor coil at pH of 8.0. NO2
− concentrations were deter-
mined colorimetrically by an imidazole buﬀered reaction
with N-1-naphtylethylenediamine. The NO3
− concentration
was quantified by subtraction of the concentrations of
NO2
− from the concentration of (NO3− + NO2−) [35]. The
samples were centrifuged at 4000 g for 3 minutes, filtered
using 0.45 μm membrane filters, and diluted in milli-Q
water before analysis (Millipore, NYSE:MIL, USA). 15NH4
+
analyses were performed after conversion to N2O using a
trace gas preconcentration unit (ANCA-TGII, SerCON, UK)
coupled to an isotope ratio mass spectrometer (IRMS) (20-
20, SerCon, UK) [35, 36]. To determine the 15N/14N ratio
of the biomass, the samples were centrifuged at 1750 g for
15 minutes and the pellet was dried at 60◦C overnight. The
15N/14N ratio was determined by an Elemental Analyzer
(EA) (ANCA-SL, SerCON, UK) coupled to the IRMS (20-20,
SerCon, UK). Analyses were triplicated.
NO measurements were done based on the principle
of chemiluminescence using Eco Physics CLD 77 AM (Eco
Physics AG, Duernten, Switzerland) with a detection limit
of 1 ppbv. Gas samples of 25 mL were collected in syringes
from the headspace of the penicillin flasks after 24 hours
of anaerobic incubation. The concentrations were calculated
by comparison with a standard curve prepared with NO
standard gas (98± 0.5 ppmv) diluted in air.
For N2O measurements, 6 mL of gas from the headspace
was collected in a vacutainer with a total volume of 12 mL
(Labco limited, Buckinghamshire, UK). One mL of this
dilution was used for analysis with a Shimadzu GC-14B gas
chromatograph (Shimadzu, Kyoto, Japan) with an electron
capture detector (ECD) and two packed columns (Porapack
Q, 80/100 mesh, 1 and 2 m). The operating conditions were
as follows: carrier gas N2 (55 mL/min), injector temperature
105◦C, column and oven temperature 35◦C, and detector
temperature 250◦C. The chromatograph was calibrated using
N2O standard gas (250 ± 13 ppmv or 25.3 ± 1.5 ppmv
in He).
For N2 analyses, 12 mL of gas from the headspace was
collected in a vacutainer (Labco limited, Buckinghamshire,
UK). The gas was analyzed with a Finnigan Trace Ultra
GC (Interscience, Breda, The Netherlands) with a thermal
conductivity detector (TCD), a precolumn (Hayesep Q,
80/100 mesh, 0.25m) and 2 packed columns (Hayesep Q,
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80/100 mesh, 2 m and Molsieve 5A˚, 80/100 mesh, 2 m). The
injector temperature was 65◦C and oven temperature 90◦C.
2.7. Calculations. All NO and N2O measurements were sub-
sequently converted to concentrations present in the growth
medium. The NO and N2O concentrations measured in the
gas phase (ppbv) were converted to molar concentrations
using the ideal gas law pV = nRT with T = 294.65 K. Taking
into account [NO]g/[NO]aq ∼= 20 and [N2O]g/[N2O]aq ∼=
1.64 at equilibrium, the NO and N2O concentrations in the
gas phase were converted to the concentration in the liquid
phase and expressed as g NO-N or N2O-N per L.
2.8. Statistical Analysis. SPSS version 16.0 (SPSS Inc.,
Chicago, USA) was used to carry out all statistical analyses.
Normality of the data and homogeneity of variances was
assessed using the Kolmogorov-Smirnov and the Levene
test, respectively. Comparison of normally distributed data
was performed with ANOVA or Tamhane; when ANOVA
indicated significant diﬀerences, means were compared using
the Bonferroni comparison test. Comparison of means
of not normally distributed data was evaluated with the
nonparametric Kruskal-Wallis test; when Kruskal-Wallis
indicated significant diﬀerences, means were compared using
the Mann-Whitney comparison test. A P-value of less than
0.05 was considered significant.
3. Results
3.1. L-Arginine as N-Source for NO and N2O Production. The
biological production of NO with L-arginine as substrate
was studied by supplementing mineral medium and feed
medium with 0, 5, or 50 mg L-arginine-N/L. Medium
supplemented with 50 mg L-arginine-N/L but not inoculated
with fecal suspension, served as a negative control. The
pH was set at 7 and NO and N2O concentrations were
analyzed after 24 hours. When L-arginine was supplemented
to the mineral medium, only traces of NO (0.28 ng NO-
N/L medium) could be detected for all the L-arginine con-
centrations. In feed medium, the mean NO concentration
after 24 hours was for all the samples around 75 ng NO-N/L
medium. No proportional eﬀect of L-arginine on the NO
production could be observed. No N2O was detected in any
of the samples.
3.2. Nitrate as N-Source for NO and N2O in Mineral Media
Optimized for Denitrification. Fecal microbiota were tested
for their ability to produce NO and N2O by denitrification.
Fecal suspensions were inoculated anaerobically for 24
hours in mineral media (with succinate as electron donor)
containing 0, 5, or 50 mg NO3
−-N/L. Nitrate was completely
consumed for all biotic conditions. None of the samples
contained nitrite in the beginning or at the end of the
incubation and after 24 hours the mean pH was 6.53± 0.35.
After 24 hours of incubation, the NO concentrations in
the mineral media remained below 1 ng NO-N/L medium
in all experiments (Figure 2(a)). A proportional eﬀect was
observed for N2O production and the amount of supplied
nitrate (Figure 2(b)). The fecal microbiota without added
nitrate did not produce N2O. However, addition of 5 and
50 mg NO3
−-N/L resulted in significant N2O production.
3.3. Nitrate as N-Source for NO and N2O in Feed Medium
3.3.1. Nitrate as N-Source for NO and N2O in Nonbuﬀered
Feed Medium. To examine whether microbiological produc-
tion of NO and N2O was possible under gastrointestinal
conditions, fecal microbiota were grown in the presence of
a complex medium simulating the conditions in the colon
(Figure 1). The feed medium was analyzed for nitrate and
a background of 0.11 mg NO3
−-N/L was measured. The
preparation of feed medium without trace levels of nitrate
was not possible. After 24 hours of incubation, the pH
dropped to 4.13± 0.05, 4.24± 0.03 and 4.47± 0.03 for 0.11,
5 and 50 mg NO3
−-N/L, respectively. The concentrations of
nitrate measured after 24 hours were below 0.5 mg NO3
−-
N/L for all biotic conditions. Nitrite at time 0 was below
0.1 mg NO2
−-N/L but after 24 hours concentrations of 0.1±
0.1 and 2.0±0.2 mg NO2−-N/L were detected for 5 and 50 mg
NO3
−-N/L, respectively. Figures 2(c) and 2(d) show the
concentrations of NO and N2O measured after 24 hours. The
NO concentration measured in the medium without nitrate
addition was 37.0 ± 0.3 ng NO-N/L. The addition of 5 mg
NO3
−-N/L increased the NO concentration slightly to 44.1±
2.5 ng NO-N/L medium. However the addition of 50 mg/L
NO3
−-N increased the NO concentration drastically to 298±
33μg NO-N/L medium. As for the mineral media, a positive
eﬀect for the N2O production with the supplemented nitrate
was observed.
3.3.2. Nitrate as N-source for NO and N2O in Buﬀered Feed
Medium. The same experimental setup as described above
was used but under buﬀered conditions (measured pH
was always between 6 and 6.8), thus avoiding fermentative
acidification during biotic incubations. Nitrate concentra-
tions decreased after 24 hours to 1.0 ± 1.5 and 3.1 ± 1.9 mg
NO3
−-N/L for 5 mg and 50 mg NO3−-N/L respectively. No
nitrite was detected. As shown in Figures 2(e) and 2(f),
the NO concentrations increased slightly when nitrate was
added. The concentration of N2O in buﬀered feed medium
supplemented with 5 mg NO3
−-N/L was comparable to the
concentration measured in the nonbuﬀered test reported
above. For the highest concentration of nitrate a lower N2O
concentration was detected compared to the nonbuﬀered test
(Figure 2).
3.4. 15N Experiment. A 15N tracer study was used to link
nitrate consumption to denitrification or DNRA by the fecal
microbiota under gastrointestinal conditions. The setup was
the same as for the buﬀered feed medium but K15NO3 (10
atom %) was used as N-source in 2 diﬀerent concentrations,
that is, 5 and 50 mg 15NO3
−-N/L (Figure 1). Table 1 gives an
overview of the nitrogen concentrations measured and the
recovery of 15N after 24 hours of anaerobic incubation. After
24 hours all nitrate was reduced and the control maintained
41.3 ± 4.5 mg NO3−-N/L. The nitrite concentrations were
stable over 24 hours of anaerobic incubation. The amount
of NO and N2O produced per volume of feed medium was
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Figure 2: NO-N and N2O-N concentrations produced after 24 hours of anaerobic incubation of the human fecal microbiota in mineral
medium (a), (b), nonbuﬀered feed medium (c), (d), or buﬀered feed medium (e), (f) with or without the addition of nitrate (n = 3).
Significant diﬀerences are indicated with a, b, or c (P < .05). Results are means ± standard deviation of 3 incubations of fecal suspension
from 1 representative person.
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Table 1: Nitrogen concentrations measured after 24 hours of anaerobic incubation of fecal microbiota in feed medium supplemented with
K15NO3(10 atom %). The N2 concentration measured in the control is subtracted from the concentrations measured in the samples. 15NH4
+
and organic 15N are recovered from K15NO3(10 atom %). Results are means ± standard deviation of 3 incubations of fecal suspension from
1 representative person.
5 mg 15NO3
−-N/L 50 mg 15NO3−-N/L 50 mg 15NO3−-N/L abiotic control
Nitrate-N (mg/L) 0 0 41.3± 4.5
Nitrite-N (mg/L) 0.1± 0.02 0.08± 0.01 0.4± 0.03
NO-N (ng/L) 111± 5a 215± 1b 2.3± 0.4c
N2O-N (ng/L) 4020± 246a 58553± 4837b 0c
N2 0 0 —
15NH4
+ (atom %) > 10 >10 0
Organic 15N (atom %) 0.05± 0.03 0.14± 0.03 0
abc significant diﬀerences between a, b, and c (P < .05).
in the same range as what was found in the buﬀered feed
medium experiment (Table 1). High ammonium concentra-
tions, 56.5 ± 6.1 mg NH4+-N/L, were present in the feed
medium at time 0. After 24 hours, concentrations reached
182±4, 210±1, 275±6, and 50.1±2.6 mg NH4+-N/L for no
extra, 5 mg NO3
−-N/L, 50 mg NO3−-N/L, and the chemical
control, respectively.
3.5. NO Production in Buﬀered Feed Medium During DNRA.
To verify if NO can be produced as a side product or as
an intermediate during DNRA, E. coli LMG 18221, a strain
capable of DNRA but not denitrification was grown anaero-
bically at 37◦C in buﬀered feed medium. After 24 hours, NO
concentrations of 170 ng NO-N/L medium were measured.
This NO concentration was twice as high compared to NO
concentrations produced by the fecal cultures.
3.6. Inhibitory Eﬀect of Fecal Supernatant on NO Production.
Figure 3(a) shows that diluting the fecal suspension 200
times before inoculation in buﬀered feed medium results
in a 75% increase in the NO concentration. There was
a diﬀerence in the NO concentration related to the fecal
suspension and optimal dilution. The optimal dilution
ranged between 1/20 and 1/200 and the increase of NO
between 50 and 75%, respectively. Higher dilutions than
1/200 yielded lower NO concentrations. The addition of
supernatant from a fecal suspension resulted in a decrease
of the NO concentration (Figure 3(b)).
3.7. Production of NO in the Colon Vessels of the SHIME. A
continuous model that simulates the gastrointestinal tract
(SHIME) was used to measure NO production by human
gastrointestinal microbiota. Feed medium containing trace
levels of nitrate (110 ± 50μg NO3−-N/L) is used to simulate
the nutritional conditions. The NO concentrations in the
headspace of the 3 colon vessels were analyzed after an
incubation period of 24 hours. In the colon ascendens,
101 ng NO-N/L SHIME suspension was measured but lower
concentrations were found in the colon transversum and
descendens (5.4 and 8.5 ng NO-N/L SHIME suspension,
respectively). A batch setup was performed to test whether
this diﬀerence was due to (i) the microbial community or
(ii) the availability of nutrients in the diﬀerent colon com-
partments. The biomass of the diﬀerent colon compartments
was washed and grown anaerobically in fresh feed medium
for 24 hours. As references, the microbial suspensions of
the diﬀerent colon vessels were incubated in parallel in
penicillin bottles with or without the addition of fresh feed.
To exclude a chemical process, cell-free supernatant of the
SHIME suspension was filtersterilized or autoclaved and
subsequently incubated. Figure 4 shows that the addition of
feed increases the NO concentrations at least 3 times but the
diﬀerence between the first colon vessel and the other 2 was
maintained. Incubation of the washed biomass showed that
even higher concentrations of NO were produced (ranging
between 220 and 250 ng NO-N/L) and that the supernatant
that was removed might have an inhibitory eﬀect on the NO
production as observed above. No chemical production of
NO was seen when the cell-free supernatant of the SHIME
suspension was incubated.
4. Discussion
Our results demonstrate that the fecal microbiota of healthy
persons are able to produce NO in concentrations up to 90 ng
NO-N/L medium when grown in conditions simulating the
colon (Figure 2(e)). Adding L-arginine to the feed medium
inoculated with fecal microbiota of a healthy person had
no eﬀect on the NO production. High amounts of nitrate
in combination with low pH resulted in substantial NO
and N2O production (Figures 2(c) and 2(d)). However, NO
and N2O were also formed under pH buﬀered conditions
(Figures 2(e) and 2(f)). These data corroborate the metabolic
capacity of the fecal microbiota to reduce nitrate and
produce NO. By using 15N tracer experiments, it was shown
that nitrate was mainly reduced to ammonium by DNRA
suggesting that NO was produced as a side product or
intermediate of this pathway. NO was detected not only in
the batch tests but also in the in vitro SHIME model.
Indirect evidence from in vitro studies demonstrates
that extracellular L-arginine increases the NO production
by eukNOS (at concentrations at which the enzyme should
be saturated), known as the “L-arginine paradox” [37, 38]
and some prokaryotic NOS proteins have been shown to
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Figure 3: NO-N concentrations in function of the diﬀerent
dilutions of fecal suspension (a) and the inhibitory eﬀect of the
supernatant of the fecal slurry (b). The inoculated medium was
incubated anaerobically for 24 hours and the NO-N concentration
measured in the headspace (n = 3). Significant diﬀerences are
indicated with a, b, or c (P < .05). Results are means ± standard
deviation of 3 incubations of fecal suspension from 1 representative
person.
produce NO in vivo [14–17]. However, our results show
that L-arginine does not promote NO production. The
reaction from L-arginine to NO is oxygen dependent what
might explain why L-arginine has no increasing eﬀect during
anaerobic growth of the fecal microbiota. Therefore, we
consider the arginine pathway for bacterial NO production
under gastrointestinal conditions as not important.
In the lower parts of the gastrointestinal tract, nitrate
originates from dietary products rich in nitrate, like spinach,
beetroot, or fennel or simply from minor levels as present
in drinking water [39]. Nitrate is reduced by the bacteria
in the oral cavity or is absorbed in the small intestine. In
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Figure 4: NO-N concentrations produced by the microbiota of
the 3 colon vessels (black = colon ascendens (CA), light grey =
colon transversum (CT), dark grey = colon descendens CD)) of the
in vitro SHIME model measured in the headspace. The microbial
suspension of the 3 vessels was incubated anaerobically for 24 hours
with or without fresh feed medium or washed and resuspended
in fresh feed medium. The supernatant of the SHIME suspension
was incubated as well in the feed medium after filtersterilisation or
autoclavation.
healthy persons, levels in the order of mg NO3
−-N/L can be
estimated in the large intestine [18] and feces were shown to
contain around 0.15 mg NO3
−-N/L [3]. Based on these data,
2 diﬀerent concentrations of nitrate (5 and 50 mg NO3
−-
N/L) were chosen for the in vitro experiments. Very low
concentrations of nitrate were measured in the feed medium
receiving no additional nitrate (110±50μg NO3−-N/L), rep-
resentative for the concentrations found in feces. When fecal
suspensions were incubated in nonbuﬀered feed medium
containing 50 mg NO3
−-N/L very high concentrations of NO
(29.8 μg NO-N/L) were measured. During the incubations,
the pH dropped to a mean value of 4.24 due to the accu-
mulation of organic acids produced by the microorganisms.
At these low pH values, a chemical reduction of nitrite to
NO (pH below 5.5) cannot be excluded [19]. In vivo, the pH
increases over the diﬀerent colon parts. Considering a pH of
6.37 ± 0.58 in the colon ascendens, 6.61 ± 0.83 in the colon
transversum and 7.04 ± 0.67 in the colon descendens [40],
a chemical reduction of nitrite to NO in vivo is not likely.
Because it was unclear whether NO was produced chemically
or biologically, a buﬀer was added to stabilize the pH between
5.7 and 8. The very high NO concentrations produced
at low pH in feed medium containing the highest nitrate
concentration were not found at neutral pH. In a study of
Sobko et al. [19] the production of NO by fecal microbiota
cultivated on ISO-sensitest agar supplemented with nitrate
was demonstrated. For the plates supplemented with 1.4 mg
NO3
−-N/L, concentrations in the range 29–3600 ppbv NO,
corresponding to 1–145 ng NO-N/L in the microbial suspen-
sion, were measured but a high variability was seen between
8 Journal of Biomedicine and Biotechnology
diﬀerent fecal samples. As the pH of the plates decreased
from 7 to 5, a chemical reduction could not be excluded.
However, it was concluded that the fecal NO generation was
not solely due to acidification of the plates [19]. We can con-
clude that the NO concentrations found in our study, which
were between 90 and 100 ng NO/L for low concentrations of
nitrate, are in the same order of magnitude.
Under anaerobic conditions, bacteria can use nitrate as
N-source in nitrate assimilation and 2 dissimilatory pro-
cesses, denitrification and DNRA. Denitrification is assumed
to be the major nitrate removal pathway in many anoxic
ecosystems like soils, sediments, and water treatment plants
[20] but information about the occurrence of this process
in the human colon is limited [26]. Denitrifying bacteria are
found in Alpha-, Beta, Gamma- and Epsilonproteobacteria,
Firmicutes, and Bacteroidetes. During denitrification NO is
produced in the nanomolar range, without reaching toxic
levels [21, 22]. When the supply of electron acceptor is
limited, it is more beneficial for the bacteria to exploit
DNRA rather than denitrification because of the higher
electron consumption [41]. Molecular and biochemical
studies have described DNRA in some enteric bacteria [42]
but information about the occurrence of this process in
complex microbial cultures including the microbiota of the
human gastrointestinal tract is limited [20]. Allison and
Macfarlane [26] reported that DNRA is the major pathway
for nitrate reduction by the fecal microbiota. Identification
based on phenotype and genotype showed that Clostridium
ramosum, Bacteroides vulgates, and the enterobacteriaceae
were mainly capable of DNRA [27]. These species are rep-
resentative for the dominant groups of the fecal microbiota
[31, 32]. By adding the stable isotope 15N in the form
of nitrate, the occurrence of all nitrate-reducing processes
under gastrointestinal conditions was studied and quantified.
Maximum 0.14 atom % of the added nitrate was used for
biomass production. High ammonium concentrations in
the medium repress nitrate assimilation and enhance the
use of nitrate for the dissimilatory processes [41]. Under
gastrointestinal conditions nitrate seems to be completely
reduced to ammonium and not to N2 gas and during this
reductive process, NO is produced in low concentrations. To
our knowledge, no studies are available indicating NO as an
intermediate in DNRA. Further proof for NO production
during DNRA was given by E. coli K12, a strain capable
of DNRA but not denitrification (data not shown) [27].
This strain produced 170 ng NO-N/L under gastrointestinal
conditions with low concentrations of nitrate (110 μg NO3
−-
N/L). Evidence for NO as an intermediate in DNRA would be
even more decisive when 15N-NO was measured during the
15N tracer study. However, equipment for 15N-NO analyses
is very specialized [43] and not in the scope of this paper.
Whether N2O is an intermediate as well or the reduction
product of a defense mechanism of bacteria to NO [44] is
not clear.
The gaseous NO concentration measured in the colon
ascendens (CA) vessel of the in vitro SHIME model was
around 15 times higher than the NO concentrations mea-
sured in the colon transversum (CT) and colon descendens
(CD). During the batch experiments incubation of the
microbial suspension from the diﬀerent colon vessels showed
that the NO concentration of the CA doubled when adding
fresh medium. The addition of fresh feed medium decreased
the diﬀerence in NO concentrations between the colon
vessels. Remarkably, when removing the supernatant of the
suspension, a 6-fold increase of NO was seen and the
diﬀerence between the colon vessels disappeared, indicating
that the availability of nutrients rather than a diﬀerence in
the microbial community was responsible for the diﬀerences
between the colon vessels. Also, a similar inhibitory eﬀect was
seen by adding the supernatant of the fecal suspension to the
inoculated buﬀered feed medium. Diluting the fecal suspen-
sion to increase NO production confirmed our observation.
A possible explanation for this inhibitory eﬀect can be the
presence of bile salts. About 5% of the bile salts secreted in
the duodenum is available to the microbiota in the colon. To
protect them, the microbiota tend to hydrolyze the bile salts
but around 5% of the nonconverted bile salts can be found
in human feces and will have toxic eﬀects on the bacteria
[45]. Diluting the fecal suspension could decrease the toxic
eﬀect and thus increase the bacterial metabolism. The same
explanation might be valid for the lower NO concentrations
in the nonbuﬀered compared to the buﬀered feed medium
for the 2 lower concentrations of nitrate. As the pH drops
during the nonbuﬀered incubations, the metabolism of the
bacteria might be suppressed leading to a lower formation of
NO.
Epithelial cells are known to produce NO through
oxidation of L-arginine by NOS [4, 5]. Roediger et al. [46]
demonstrated elevated luminal NO in the rectum of patients
with active IBD. Although bacterial origin was considered,
the NO was believed to originate from the mucosa [46].
Several years later, NO concentrations were measured in the
rectum that was not cleared from luminal bacteria and again
NO concentrations in patients with active IBD were elevated.
A bacterial origin for the NO production was proposed [3].
Our results corroborate that the fecal microbiota actively
produce substantial levels of NO, even from traces of nitrate.
In vitro the fecal microbiota were shown to produce around
100 ng NO-N/L. In vivo no NO was found in the rectum of
healthy volunteers but 40 ng NO-N/L was measured in the
rectum of patients with active IBD [3]. Externally added NO
(in the form of gas or NO donor) has been shown to alter the
mucosal barrier function [47–49] and to have an eﬀect on the
metabolism of colonocytes [50]. As it was strongly suggested
that several constitutive and/or inducible defense systems
exist in mammalian cells that neutralize the damaging eﬀects
of NO [51], the high rectal levels of NO in IBD patients
and the low levels in healthy persons might indicate that the
expression of these defense mechanisms in IBD patients is
ineﬀective.
In this work, the human fecal microbiota were shown
to produce NO from trace levels of nitrate under gas-
trointestinal conditions. Moreover, our data indicate that
NO was produced by DNRA and not by denitrification or
the L-arginine pathway. Studying the interaction between
bacterially produced NO and the host epithelial cells might
be pivotal in the etiology of inflammatory diseases of the
gastrointestinal tract.
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